Intercurrent all bleed rate (bleeds/mo) by treatment arm and phase of ITI
| . | Dose (n) . | Mean . | Median . | IQR . | P . |
|---|---|---|---|---|---|
| Phase 1 | Low (58) | 0.623 | 0.564 | 0.093-0.886 | .00024 |
| High (57) | 0.282 | 0.000 | 0.000-0.440 | ||
| Phase 2 | Low (27) | 0.127 | 0.000 | 0.000-0.073 | .283 |
| High (22) | 0.087 | 0.000 | 0.000-0.000 | ||
| Phase 3 | Low (24) | 0.150 | 0.000 | 0.000-0.148 | .552 |
| High (22) | 0.033 | 0.000 | 0.000-0.000 | ||
| Phase 4 | Low (24) | 0.175 | 0.150 | 0.000-0.290 | .112 |
| High (22) | 0.102 | 0.000 | 0.000-0.231 |
| . | Dose (n) . | Mean . | Median . | IQR . | P . |
|---|---|---|---|---|---|
| Phase 1 | Low (58) | 0.623 | 0.564 | 0.093-0.886 | .00024 |
| High (57) | 0.282 | 0.000 | 0.000-0.440 | ||
| Phase 2 | Low (27) | 0.127 | 0.000 | 0.000-0.073 | .283 |
| High (22) | 0.087 | 0.000 | 0.000-0.000 | ||
| Phase 3 | Low (24) | 0.150 | 0.000 | 0.000-0.148 | .552 |
| High (22) | 0.033 | 0.000 | 0.000-0.000 | ||
| Phase 4 | Low (24) | 0.175 | 0.150 | 0.000-0.290 | .112 |
| High (22) | 0.102 | 0.000 | 0.000-0.231 |